Stay updated on Nivolumab Relatlimab Advanced Chordoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.

Latest updates to the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page
- ChecktodayChange DetectedThe page’s footer revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a minor site release rather than a change to the clinical trial content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated to v3.4.3 on the page, replacing the previous v3.4.2.SummaryDifference0.1%

- Check72 days agoChange DetectedThe change is a minor software revision from v3.4.1 to v3.4.2 and does not alter study content, eligibility criteria, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedMinor site version update from Revision: v3.4.0 to v3.4.1 with no visible changes to study content or page functionality.SummaryDifference0.1%

- Check88 days agoChange DetectedGlossary and related terminology (including a Show glossary option and MeSH terms) were added, and a non-critical item ('No FEAR Act data') was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference55%

Stay in the know with updates to Nivolumab Relatlimab Advanced Chordoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.